BACKGROUND: There is a paucity of data about the impact of changes in anthropometric measurements on the risk of mortality events, especially in men.
INTRODUCTION
Before the 1990s, obesity was mainly a public health problem, only in Western countries. But over recent decades, it has escalated to a global issue referred to as the 'obesity epidemic'. 1 Developing countries are embracing the adverse dietary and activity habits of Western lifestyle, as consequences of globalization. 2, 3 Although the causes of this obesity epidemic are uncertain, many argue that only sedentary lifestyle and dietary habits are the two main stems of the obesity epidemic, although it has been shown that the obesity epidemic is much more complicated than exposure to only these two main environmental changes. 4 It is estimated that 500 million adults are obese and 1.5 billion are overweight or obese worldwide. 5 In the Middle East and North Africa regions, epidemiologic studies highlight alarmingly rising trend in the prevalence of obesity, especially among young populations. 6 Numerous epidemiologic studies have found obesity to be an established risk factor for mortality. 7 However, the protective effect of overweight or even obesity has been revealed, especially in elder population 8, 9 or those with cardiovascular disease (CVD). 9, 10 On the other hand, controversies surround the potential risk and benefits of weight loss. 7, 11 Many population-based studies have shown that weight loss is associated with greater risk of mortality, which is contrary to the ideas associated with the adverse effect of obesity. Recently, these controversial debates known as 'obesity paradox' have aroused much interest and many explanations have been proposed. 12 There is a scarcity of information about the role of changes in fat distribution as assessed by different anthropometric measurements and risk of subsequent mortality events, 6,13,14, and to the best of our knowledge, there are no data in this field in the Middle East with high prevalence and incidence of obesity. In the present study, we aimed to examine the impact of changes in different anthropometric measurement on all-cause mortality among adult males of the Tehran Lipid and Glucose Study (TLGS). We also used cubic spline modeling to examine the possible nonlinear association between anthropometric change and mortality.
MATERIALS AND METHODS

Study population
The TLGS is an ongoing prospective study aimed at determining the risk factors and outcomes for non-communicable disease being conducted on a representative sample of 15 005 residents of district-13 of Tehran, aged 3 years and over. 15 Subjects were categorized into the cohort and intervention groups, the latter to be educated for implementation of lifestyle changes. 16 As designed in the TLGS protocol, the whole population was followed up in several phases, about 3.6-year intervals. Of the 6610 male sample, 3533 subjects, aged ⩾ 30 years, were examined in phase I (1999) (2000) (2001) . After excluding those with prevalent CVD at baseline (n = 356), there were 3177 participants. Those with missing anthropometric data at baseline and follow-up visit (phase II in [2002] [2003] [2004] [2005] were also excluded (n = 1372), leaving 1805 subjects, who were monitored 1 for a mean follow-up period of 6.6 years. Written informed consent was obtained from all subjects, and the ethical committee of the Research Institute for Endocrine Sciences approved this study.
Clinical and laboratory measurements
A trained interviewer collected information that included demographic data, medical history, family history of CVD, medication use and smoking habits, using a validated questionnaire. Details of measurements of weight, height, waist circumference (WC) as well as systolic blood pressure and diastolic blood pressure have been reported elsewhere. 15 Body mass index (BMI) was calculated as weight (kg) divided by square of height (m 2 ).
From all study participants after 12-14 h of overnight fasting, a blood sample was drawn between 7:00 and 9:00 AM. Details of measurements of plasma glucose and total cholesterol have been reported elsewhere. 15 
Definition of terms and outcome
Smoking included never, past or current groups. Furthermore, current group was categorized into three subgroups including participants who smoked o10, 10-20 and 420 cigarettes daily. Education was categorized into three groups: (i) Illiterate/primary school, (ii) Cycle/diploma and (iii) Higher than diploma. 17 History of CVD was defined as previous ischemic heart disease and/or cerebrovascular accidents. Family history of premature CVD reflected any prior diagnosis of CVD in first-degree female relatives, aged below 65 years or first-degree male relatives under 55 years. As applied in other studies, we also categorized anthropometric changes into four groups according to their percentage of change Phase2 measurement -phase1 measurement Phase1 measurement
100
. Group 1, change percentage o − 5%; Group 2, − 5% ⩽ change percentage o+5% reference group; Group 3, 5% ⩽ change percentageo10%; and Group 4, change percentage ⩾ 10%; the similar approach was applied by Yun et al. 18 The process of gathering data on outcomes has been published in detail earlier. 15 To summarize, each year in a continuous manner, using telephone call, a trained nurse questioned each participant for any medical event leading to hospitalization in the past year and whether a related event had occurred; complementary data were collected by a trained physician during a home or hospital visit.
Statistical analysis
Cox proportional hazard regression was implemented to assess the hazard ratios (HRs) of anthropometric change groups for all-cause mortality. Time to event was defined as the time of censoring or having event, whichever came first. We censored individuals at the time of leaving the residence area and loss to follow-up or being in the study until March 2010 without mortality. Two models were reported. To select covariates to be included in multivariate Cox regression models, univariate analysis was used for each covariate candidate (age, history of premature CVD, baseline BMI, baseline anthropometric measures, education, intervention, baseline systolic blood pressure and its change until phase II, baseline diastolic blood pressure and its change until phase II, baseline total cholesterol and its change until phase II and baseline fasting plasma glucose and its change until phase II); following this, each covariate that had a P-value less than 0.2 in the univariate analysis was selected to be included in a multivariate Cox proportional regression analysis. Model 1 was adjusted for confounding variables (age, smoking status, educational level, intervention, baseline BMI and each anthropometric measurement at baseline). Model 2 included variables from Model 1 plus further adjustments for mediator variables (baseline fasting plasma glucose and its change and baseline systolic blood pressure). The proportional hazard assumption in the Cox model was assessed with the Schoenfeld residual test and all proportionality assumptions were appropriate.
Interactions between age, smoking, intervention and anthropometric changes with mortality were tested by the log-likelihood ratio test in multivariate analysis. As there were no significant interactions between age, smoking and intervention with anthropometric changes in prediction of mortality, we did not stratify our analysis according to smoking, age status and intervention group (all P40.05). Furthermore, to assess the shape and strength of the associations between anthropometric changes and mortality instead of using arbitrary predetermined cut-points, we used multivariate restricted cubic splines. Furthermore, applying normal distribution of anthropometric measures, we placed our knots at tertiles. A spline function was assumed to be significant if at least one of the splines differed significantly from zero assessed by an overall Wald test. 14, 19, 20 
RESULTS
The study sample consisted of 1805 men with mean (s.d.) age of 48.47 years (12.87). During 6.6 years of follow-up, 88 cases of mortality occurred. The corresponding incidence rate of mortality was 48.8 (confidence interval; 39.6-60.2) per 10 000 person-years. The comparison between those with missing data of anthropometric measurements in either phase I or II or loss to follow-up (nonrespondents) and those with anthropometric data in both phases I and II who had follow-up until the end of the study (respondents) is shown in Table 1 . The respondents were older and had lower rates of smoking. The mean values (s.d.) of anthropometric measurements at baseline and phase II are given in Table 2 . There were increasing trends in all of the anthropometric measurements.
Those who participated in the intervention program had lower increase in BMI change (0.38 vs 0.56 kg/m 2 , P-value = 0.022), hip circumference (HC) change (1.5 vs 3.0 cm, P-value o 0.01) and WC change (4.7 vs 5.2 cm, P-value = 0.001) compared with the control group. Table 3 highlights the HRs of the anthropometric change group for all-cause mortality, given group 2 as reference. In model 1 adjusted for age, smoking, education, intervention, family history of premature CVD, baseline anthropometrics and BMI, the HR of group 1 for HC and group 4 for waist to hip ratio (WHR) changes reached significant levels. The HRs of mortality were 3.13 (1.28-7.64), 0.75 (0.43-1.31) and 0.82 (0.23-2.99) for the first, third and fourth groups of HC changes, respectively. As for the WHR change groups, the HRs were 1.80 (0.75-4.33), 1.21 (0.70-2.1) and 2.32 (1.25-4.3) for the first, third and fourth groups, respectively. After further adjustment for mediator covariates (Model 2), surprisingly, individuals whose HC reduced over 5% had a threefold increase in risk for mortality outcome (HR; 3.13 (1.28-7.64)). Among WHR groups, the HR was 2.34 (1.25-4.37) for the fourth group. The corresponding HRs for BMI did not reach statistical significance, neither in model 1 nor after further adjustment for mediator covariates. Regarding WC changes, we found positive risk for changes o − 0.5% or 4+10%; however, this magnitude did not reach to the significant level. Figure 1 shows the shape of the association between the log HRs of anthropometric changes and all-cause mortality using cubic spline function with 3 knots. A significant nonlinear association between WC and WHR changes with mortality was shown. As for HC changes, the risk of mortality increased remarkably as HC changes decreased compared with those with minimum changes; however, on the right side of the figure, there was no superiority for the risk of mortality with increasing in HC change compared with those with minimum changes. Also, for BMI changes, none of the splines differed significantly from zero (P-value wald test40.4).
DISCUSSION
In a prospective cohort study, during 6.6 years of follow-up of adult Tehranian men, we found that changes in anthropometric measurements were associated with mortality risk. Changes in WHR showed a nonlinear association with incident mortality, which was reached to more than two times in those with ⩾ 10% increase in the ratio. Moreover, for the first time, we demonstrated that decrease of ⩾ 5% in HC was strongly associated with excess risk of mortality, which did not attenuate after mediator adjustment.
Numerous epidemiologic studies have assessed the association between baseline anthropometric measurements and risk of mortality events during follow-up, 7, 11, 21, 22 but there is a paucity of information about the impact of changes in anthropometric measurements on the risk of mortality. 13, 14 Berentzen et al. 14 
in a
Danish population demonstrated that changes in BMI were inversely associated with the risk of mortality events. They highlighted that each 1 kg/m 2 increase in BMI decreased the risk of mortality by 12% in male population in a linear trend (HR: 0.88 confidence interval; (0.80-0.95)). In a retrospective study of Korean men, Yun et al 18 showed that the HR of those with over 10% increase in BMI change was 1.16 (1.07-1.25) for all-cause mortality events compared with the stable group with changes − 5% to +5%. In the present study, we did not demonstrate the harmful effect of BMI decrease on mortality outcome. Furthermore, weight loss has been shown to correlate with improvement in CVD risk factors such as hypertension, dyslipidemia and diabetes. 23 Strandberg et al. 24 highlighted that men who moved from overweight to normal weight had the highest CVD risk in the middle life and worst prognosis in the late life. To explain these results, some studies have shown that during weight loss, visceral fat disappears earlier compared with subcutaneous fat, especially in the peripheral region. 25, 26 Therefore, despite the benefits of weight loss in reducing the risk of CVD, if weight loss continues, the beneficial effects of subcutaneous fat would vanish and the risk of mortality increase. Moreover, it has been shown that many weight loss methods such as smoking, fasting and diet drugs can result in harmful effects. 27 Surprisingly, findings of the National Health and Nutrition Examination Survey revealed that the ideal weight for increasing the life span is overweight defined as BMI 23-30 kg/m 2 . 28, 29 Regarding WC changes, we showed a nonlinear association between WC change and incident mortality. Loss of visceral fat independent of general adiposity was associated with more than 68% increase in the risk of mortality, which was not significant; however, Berentzen et al. 14 
found a linear positive association between mortality and waist circumference changes.
On the basis of the worldwide epidemiologic information, WHR has been found to be a more efficient predictor of mortality than WC or BMI. 21, 30, 31 An increased WHR may reveal a larger intraabdominal fat mass or a decreased gluteo-femoral muscle mass, two body parts that are not well captured by applying BMI alone. 21 Despite the numerous studies that have investigated the role of baseline WHR for mortality events, for the first time, we investigated the changes in WHR for future risk of mortality and found a nonlinear association between WHR changes and mortality. The risk was significant (over twofold) for those with ⩾ 10% increase in WHR, compared with those with stable change.
Recently, there are ongoing debates about the unexpected impact of HC on mortality outcome. Many studies have found adverse effect of small hip size on CVD and mortality outcomes. 32 Bigaard et al. 33 showed that 10% increase in HC decreased the risk of total mortality by 25% (HR; 0.75 (0.65-0.86)) and 35% (HR; 0.65 (0.58-0.74)) among adult women and men, respectively. In a Danish population, Heitmann et al. 34 showed positive effects of large HC on CVD and CHD morbidity and mortality in women.
Recently, in a systematic review, Heitmann et al. 32 concluded that hip size was inversely associated with CVD and mortality. Furthermore, previous studies have shown that loss of HC value may reflect loss of lean tissue, especially among men. 35 Also, there are other studies that have shown the association between wasting of leg muscle mass and excess risk of cardiovascular and metabolic disease. 36 In the present study, we showed that short-term decrease of ⩾ 5% in HC strongly increases (over threefold) the risk of total mortality; however, we did not find any evidence about the protective effects of short-term increase in HC on mortality outcome. In our study, compared with control group, those who attended lifestyle modification classes and nutritional education had significantly lower increase in anthropometric measurements, but the effect of anthropometric changes on total mortality was not modified by our intervention group (P-value for interaction 40.40), which might be due to short-term of follow-up and limited number of events. Recently, lots of attention have been focused on the effect of intentional weight loss on mortality. 22, [37] [38] [39] [40] [41] The findings of National Health Interview Survey 22 in the United States revealed that unintentional weight loss was associated with higher risk of mortality, whereas the intentional weight loss was associated with lower risk of mortality. Also, a study conducted among men aged 55-75 years of British Regional Heart Study found that intentional weight loss for personal purpose reduced the risk of all-cause mortality but did not have any impact on CVD mortality. On the other hand, many studies have shown higher risk of mortality in those with weight loss, regardless of whether it was intentional or not. 22, [38] [39] [40] [41] Some limitations of our study merit mentioning; first, because of limited number of mortality events during the relatively shortterm follow-up, this study had limited power to assess the effect of anthropometric changes (especially for WC and BMI) for mortality events. Second, we did not have any information regarding the intentional or unintentional weight changes during the follow-up. Finally, the current study was conducted on Middle East Caucasians; hence, it is not possible to extrapolate our finding to other ethnicities. There are some strengths of this study which should be noted; we consider different anthropometric measurements to assess the relationship with mortality, rather than just BMI as suggested by Harrington et al. 11 In the present study, we reported the actual measurements of variables rather than selfreported data. It has been shown that self-reporting the anthropometric variables can lead to data misclassification, as obese individuals are more likely to underreport their weight compared with normal weight persons 42, 43 which can lead to biased mortality HR estimation. 44 Also, our study was a large representative sample of Iranian urban population with very reliable surveillance for mortality event.
In conclusion, to the best of our knowledge, this is the first prospective cohort study to report the significant association between changes in HC and WHR and incident mortality in Middle Eastern men. Our findings advise to consider increase in WHR and decrease in HC to find men at increased risk for all-cause mortality.
